Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial

Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-24T02:24:02.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The Record History now includes an addition of Revision v3.3.2 and a deletion of Revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T11:28:52.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The notice about a lapse in government funding and the NIH operating status has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-18T07:10:51.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The version history shows ongoing updates to the trial record, with multiple versions adding recruitment status and study status. The latest version on 2024-07-30 also updates the study design and the contact/locations information.
    Difference
    0.1%
    Check dated 2025-11-03T21:13:59.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Summary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.
    Difference
    13%
    Check dated 2025-10-06T06:34:01.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-29T03:15:08.000Z thumbnail image

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.